Nanobody approval gives domain antibodies a boost
نویسندگان
چکیده
منابع مشابه
Free access to journals gives Kenyan science a boost.
Dr Hilary Rono shudders to think what life for him and his colleagues in the medical profession — particularly in developing countries — was like before the Internet. Rono is just about to complete his masters degree in ophthalmology at the University of Nairobi. The Internet has been key to his studies, especially the Health InterNetwork Access to Research Initiative (HINARI). The WHO programm...
متن کاملPatent dispute: Delhi High Court gives a boost to access to affordable medicines.
The Delhi High Court has rejected the petition filed by Bayer Corporation seeking to stop the Drugs Controller of India (DCGI) from registering a generic version of a patented cancer drug. The case was filed in 2008 by Bayer to try and introduce "patent linkage" which involves linking the registration (marketing approval) of drugs with their patent status. If Bayer's plea for "patent linkage" h...
متن کاملMantle dynamics. Sea-floor study gives plumes from the deep mantle a boost.
Earth’s interior is like a pot of boiling water— very viscous, very slowly churning water. The great debate about how Earth’s interior operates to shed internal heat and shape the surface began with disagreements over whether two layers in the pot—the upper and lower mantle—always remain separate, like oil and water. That debate ended when seismologists imaged Earth’s cold, brittle surface scum...
متن کاملApproval of the first biosimilar antibodies in Europe
In a defining moment for the European Medicines Agency (EMA) and the biopharmaceutical industry, on June 27, 2013 EMA's Committee for Medicinal Products for Human Use adopted a positive opinion for two biosimilar infliximab products (Celltrion's Remsima® and Hospira's Inflectra®), and recommended that they be approved for marketing in the European Union (EU). The European Commission's decision ...
متن کاملAtomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic β2-microglobulin variant
Department of Molecular and Cellular Interactions, Vlaams Instituut voor Biotechnologie, Pleinlaan 2, B-1050 Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium; Grenoble Outstation, European Molecular Biology Laboratory and Unit of Virus Host-Cell Interactions, 6 rue Jules Horowitz, BP181, 38042 Grenoble Cedex 9, France; and Departm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Drug Discovery
سال: 2019
ISSN: 1474-1776,1474-1784
DOI: 10.1038/d41573-019-00104-w